[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:prolymphocytic-leukemia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":33,"states":34},"Prolymphocytic Leukemia",4,[7,15,21,27],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06859424","A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation",[11],"Phase 2","RECRUITING","2026-08-26T02:15:31.806698Z","2026-05-05T02:43:28.740200Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT03314974","Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders",[11],"2026-08-26T02:16:14.341106Z","2026-05-05T02:43:28.206546Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT05805605","Allo HSCT Using RIC and PTCy for Hematological Diseases",[11],"2026-08-26T02:17:29.353236Z","2026-05-05T02:43:28.075410Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT04195633","Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies",[11],"2026-08-26T02:17:07.954622Z","2026-05-05T02:43:27.479357Z",[],[]]